BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper Robotic Instrumentation and Molecular Testing

23-Jun-2006

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced the signing of an agreement with BioReference Laboratories of Elmwood Park, NJ (BRLI) for BD to supply BRLI with instrumentation and reagents for testing and diagnosis of sexually transmitted infections (STI).

Under this agreement testing for Chlamydia trachomatis and Neisseria gonorrhoeae will be run on the SCARA robotic automation platform of the BD Viper(TM) System. BD will be the primary supplier to BioReference for testing of these two infectious diseases.

Other news from the department business & finance

These products might interest you

Blotting standards and reagents

Blotting standards and reagents by Cytiva

Western blotting standards and reagents

Blotting the course to effective detection of proteins from sample preparation to analysis

reagents
Micro-Dx™ CE IVD

Micro-Dx™ CE IVD by Molzym

Fully automated from sample to PCR analysis

Rapid identification of bacteria and fungi without time-consuming cultivation

DNA extraction kits
DNA-free Taq Polymerases and Mastermixes

DNA-free Taq Polymerases and Mastermixes by Molzym

DNA-free reagents for unrivalled sensitivity in molecular biology

Purity that makes the difference

PCR accessories
Greener Alternative Products

Greener Alternative Products by Merck

Sustainable laboratory products for environmentally conscious research

Over 2,500 ecological alternatives to reduce your laboratory footprint

consumables
Loading...

Most read news

More news from our other portals